Robert Bayless, MD
Orthopaedic Surgery · Irving, TXNPI 1346287604
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Kyocera Medical Technologies, Inc. accounts for 85.3% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $16,998, more than ten times the $1,248 reported in 2019.
Across 83 payments — averaging $357.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyocera Medical Technologies, Inc.$25K
- Tracpatch Health, Inc$1K
- Pylant Medical$617
- Omnilife Science, Inc$504
- UOC USA Inc$294
- Smith+Nephew$222
- plus $2K from 23 others
What the payments were for
- Consulting fees$11,20038%
- Travel & lodging$13,64846%
- Food & beverage$4,27114%
- Education$5202%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kyocera Medical Technologies, Inc. | 5 | $25,283 |
| Tracpatch Health, Inc | 10 | $1,144 |
| Pylant Medical | 3 | $617 |
| Omnilife Science, Inc | 4 | $504 |
| UOC USA Inc | 3 | $294 |
| Smith+Nephew | 3 | $222 |
| Shalby Advanced Technologies, Inc. | 2 | $218 |
| Medtronic(2 entities) | 5 | $199 |
| Johnson & Johnson(2 entities) | 8 | $190 |
| Pacira Pharmaceuticals Incorporated | 4 | $167 |
| AbbVie | 2 | $140 |
| Ferring Pharmaceuticals Inc. | 6 | $92 |
| Avanos Medical | 4 | $78 |
| Bioventus LLC | 3 | $68 |
| Molnlycke Health Care US, LLC | 3 | $64 |
| Linvatec Corporation | 1 | $61 |
| Nevro Corp. | 1 | $38 |
| Globus Medical | 1 | $38 |
| Pacira Therapeutics, Inc. | 2 | $31 |
| Orthofix Medical, Inc. | 2 | $30 |
| Electronic Waveform Lab, Inc. | 3 | $24 |
| Davol Inc. | 1 | $23 |
| Vertex | 1 | $22 |
| Averitas Pharma Inc. | 1 | $20 |
| Mimedx Group, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Painteq LLC | 1 | $15 |
| Stryker | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,639 in reported general payments places this provider in the 80th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 147 | $2,336 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 128 | $1,783 |
| Ondansetron OdtOndansetron | 98 | $1,125 |
| Meloxicam | 116 | $338 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $273 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 20 | $228 |
| Tramadol Hcl | 48 | $203 |
| Methylprednisolone | 17 | $113 |
| Gabapentin | 13 | $97 |
| Azithromycin | 14 | $83 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Irving
- Brian StrausIrving$213K
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.